MidFirst Bank’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
VCM
VPM
MidFirst Bank's AMGN Position: Q2 2026 in Review
MidFirst Bank reduced its Amgen (AMGN) stake by 4.9% in Q2 2026, selling an estimated $456K and leaving 25,893 shares worth $9.38M. The position accounts for 0.67% of the portfolio, ranked #40.
MidFirst Bank first reported a position in AMGN in Q4 2025 and has held it in 3 quarters since. The position peaked at $9.58M in Q1 2026. 2,737 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- MidFirst Bank held 25,893 shares of Amgen worth $9.38M as of Q2 2026.
- MidFirst Bank sold 1,333 Amgen shares in Q2 2026, an estimated $456K.
- Amgen made up 0.67% of MidFirst Bank's portfolio in Q2 2026, its #40 holding.
- MidFirst Bank first reported a position in Amgen in Q4 2025 and has held it in 3 quarters since.
- MidFirst Bank's Amgen position peaked at $9.58M in Q1 2026.
- 2,737 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on MidFirst Bank's 13F filing for Q2 2026, filed 7 Aug 2026.